Healius Limited ( (AU:HLS) ) has issued an announcement.
Healius Limited has completed the sale of Lumus Imaging to Affinity Equity Partners for $822 million, allowing Healius to focus on its pathology strategy and streamline operations. The transaction will enable Healius to pay a special dividend and provide transitional services to Lumus Imaging for up to eighteen months, ensuring a smooth transition for both the company and its patients.
More about Healius Limited
For over 30 years, Healius Limited has been a leading healthcare company in Australia, dedicated to providing quality, affordable, and accessible healthcare services. With a network of centers and over 8,500 employees, Healius specializes in offering specialty pathology services across the country to consumers and their referring practitioners.
YTD Price Performance: -7.93%
Average Trading Volume: 1,194
Technical Sentiment Signal: Strong Buy
Current Market Cap: €573.6M
For a thorough assessment of HLS stock, go to TipRanks’ Stock Analysis page.